Nouveau Life Pharmaceuticals Inc (NOUV)
OTHER OTC:NOUV
US Market
Holding NOUV?
Track your performance easily

Nouveau Life Pharmaceuticals (NOUV) Income Statement

28 Followers

Nouveau Life Pharmaceuticals Income Statement

Last quarter (Q ), Nouveau Life Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Nouveau Life Pharmaceuticals's net income was $-125.57K. See Nouveau Life Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 07Jun 06Jun 05Jun 04Jun 03
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 503.31K$ 357.25K$ 267.32K$ 318.01K$ 229.36K$ 180.11K
Operating Income
$ -503.31K$ -357.25K$ -267.32K$ -318.01K$ -229.36K$ -180.11K
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -18.31K$ -9.49K$ -1.07K$ -4.51K-$ -60.00
Pretax Income
------
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -503.31K$ -357.25K$ -256.82K$ -401.43K$ -312.25K$ -254.00K
Basic EPS
$ >-0.01$ -0.01$ -0.01$ -0.02$ -0.01$ -0.01
Diluted EPS
$ >-0.01$ -0.01$ -0.01$ -0.02$ -0.01$ -0.01
Basic Average Shares
$ 120.34M$ 28.31M$ 25.94M$ 24.33M$ 22.35M$ 21.60M
Diluted Average Shares
$ 120.34M$ 28.31M$ 25.94M$ 24.33M$ 22.35M$ 21.60M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 503.31K$ 357.25K$ 267.32K$ 318.01K$ 229.36K$ 180.11K
Net Income From Continuing And Discontinued Operation
$ -503.31K$ -357.25K$ -256.82K$ -401.43K$ -312.25K$ -254.00K
Normalized Income
$ -485.00K$ -347.75K$ -255.75K$ -396.92K$ -312.25K$ -253.94K
Interest Expense
------
EBIT
$ -503.31K$ -357.25K$ -267.32K$ -318.01K$ -229.36K$ -180.11K
EBITDA
$ -235.59K$ -223.41K$ -214.32K$ -204.21K$ -139.02K$ -180.11K
Currency in USD

Nouveau Life Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis